# A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

> clinical trial · VERIFIED · 2026-09-03

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Lymphoma

- Company: Hoffmann-La Roche
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06084936

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.